Aciclovir (Topical)
Rx / OTC
Therapeutic ClassAntiviral
Common Dose5% Cream
RouteTopical
PregnancyCategory B / C (use if clearly needed)
Indications ▼
Cold sores (Herpes labialis)
Herpes simplex virus skin infections
Prophylactic use in immunocompromised patients (limited)
Mechanism & Pharmacokinetics ▼
Mechanism: Guanosine analogue that inhibits viral DNA polymerase after phosphorylation by viral thymidine kinase, selectively preventing viral replication.
Pharmacokinetics: Minimal systemic absorption. Concentrates in skin lesions. Metabolized minimally in liver; excreted unchanged in urine in trace amounts.
Dosage & Administration ▼
| Patient Group | Dose | Frequency / Duration |
|---|---|---|
| Adults & Adolescents | Apply 5% cream | 5 times daily for 4–5 days |
| Children (≥2 years) | Apply 5% cream | 5 times daily for 4–5 days |
Side Effects ▼
Local irritation, burning, or stinging at application site
Itching or mild erythema
Rare: Hypersensitivity reactions, rash beyond application site
Contraindications ▼
Hypersensitivity to aciclovir or valaciclovir
Open or severely inflamed skin lesions (consult physician)
Drug Interaction ▼
Minimal systemic absorption, so drug interactions are rare
Caution with nephrotoxic drugs if systemic absorption occurs
Pregnancy & Lactation ▼
Topical use generally considered safe if clearly needed
Compatible with breastfeeding (minimal systemic absorption)
Clinical / Research Summary ▼
Antiviral Efficacy: Aciclovir topical has demonstrated potent activity against herpes simplex virus (HSV-1 and HSV-2), effectively reducing viral replication and lesion duration.
Clinical Studies: Multiple randomized controlled trials show that 5% aciclovir cream applied 5 times daily shortens healing time of cold sores by 1–2 days compared to placebo.
Prophylactic Use: Topical aciclovir may decrease the frequency of recurrent herpes labialis in patients with frequent outbreaks.
Safety Profile: Well tolerated with minimal local irritation; systemic absorption is negligible, making it safe for immunocompetent adults and children.
Combination Therapy: Often used alongside systemic antivirals in severe or widespread cases, though topical alone suffices for localized lesions.
Research Insights: Recent studies suggest that early initiation (within 24 hours of symptom onset) maximizes efficacy. Ongoing trials are evaluating newer formulations for faster absorption and reduced application frequency.
Patient Counseling Points ▼
Wash hands before and after applying cream
Apply to affected area only
Complete full course even if lesions improve
Avoid contact with eyes or mucous membranes
Storage & Handling ▼
Store at 20–25°C, protect from light
Keep out of reach of children
Do not freeze
Brand Names (Bangladesh & Global) ▼
Bangladesh (Local Brands):
Global / International Brands:
Medical Disclaimer: This clinical summary is for educational purposes only. Always consult a qualified healthcare provider before use.